Autonomic reactivity and clinical severity in children with sickle cell disease

Sarah R Pearson1, Abbey Alkon, Marsha Treadwell

  • 1School of Public Health, University of California, Berkeley, 94720-1190, USA.

Insights

Autonomic nervous system reactivity in children with sickle cell disease is linked to disease severity and behavioral issues. Understanding these individual differences may help explain variations in complications and symptoms.

Area of Science:

  • Pediatric Health
  • Autonomic Nervous System Research
  • Hematology

Background:

  • Individual differences in autonomic nervous system (ANS) reactivity are linked to health outcomes.
  • Research on ANS reactivity in children with chronic diseases, particularly sickle cell disease (SCD), is limited.
  • Understanding ANS function in pediatric SCD is crucial for managing health and behavioral symptoms.

Purpose of the Study:

  • To investigate the associations between ANS reactivity, clinical severity, family stressors, and mental health symptoms in children with homozygous SCD.
  • To explore how ANS responses to various challenges relate to disease burden and behavioral patterns.
  • To identify potential biological markers for symptom variability in pediatric SCD.

Main Methods:

  • Cross-sectional study of 19 children with homozygous SCD.
  • Utilized parent-completed questionnaires, medical record reviews, and laboratory-based ANS assessments.
  • Measured ANS responses (parasympathetic withdrawal, sympathetic activation) during social, cognitive, physical, and emotional challenges.

Main Results:

  • Autonomic reactivity showed significant associations with both clinical severity and externalizing behavior symptoms.
  • Greater parasympathetic withdrawal correlated with more severe SCD (r = -0.45, p < 0.05).
  • Increased sympathetic activation was linked to more externalizing behaviors (r = 0.44, p < 0.05).
  • Family stressors were associated with internalizing behaviors, but not ANS reactivity or clinical severity.

Conclusions:

  • Individual differences in ANS reactivity may explain variations in painful episodes, physical complications, and behavioral symptoms in children with SCD.
  • ANS reactivity presents a novel, biologically plausible pathway for understanding symptom heterogeneity in pediatric SCD.
  • Further research into ANS function could inform targeted interventions for children with sickle cell disease.

Related Concept Videos